Brief: Theratechnologies Announces Path To Resume Th1902 Clinical Development
Feb 16 (Reuters) - Theratechnologies Inc TH.TO :
* THERATECHNOLOGIES ANNOUNCES PATH TO RESUME TH1902 CLINICAL
DEVELOPMENT
* THERATECHNOLOGIES INC - COMPANY INTENDS TO PROMPTLY AMEND
PROTOCOL AND RE-SUBMIT TO FDA
Source text for Eikon: ID:nGNX6fmtzs
Further company coverage: TH.TO
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Theratechnologies
See all newsBrief: Theratechnologies Receives Final Court Approval On To Be Acquired By Future Pak
Brief: Theratechnologies Inc - Iss And Glass Lewis Recommend Voting 'For' Future Pak Arrangement
Canadian drugmaker Theratechnologies beats Q2 revenue estimates on strong demand
Brief: Theratechnologies Enters Into Definitive Agreement To Be Acquired By Cb Biotechnology, An Affiliate Of Future Pak
Brief: Theratechnologies Inc Decided To Further Evaluate Potential Sale Of Company Through An Open And Non-Exclusive Process